Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for DPNP with and without MDD
NCT00844194Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of duloxetine in diabetic polyneuropathy (DPN), sponsored by Boehringer Ingelheim. Started Feb 2009; status: completed.
02
Drugs
duloxetine
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT00844194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00844194.